Antibody | Epitope/Target | Manufacturer |
---|---|---|
N-terminal Aβ-antibodies | ||
mAb 82E1 | Neoepitope Aβ1-5 | IBL, Hamburg, Germany |
mAb 6E10 | Aβ5-10 | Covance, Berkeley, CA, USA |
Mid-domain Aβ-antibodies | ||
mAb 6F/3D | Aβ8-17 | Novocastra, Newcastle, U.K. |
mAb 4G8 | Aβ17-24 | Covance |
C-terminal Aβ-antibodies | ||
rpAb 40 | Aβx-40, neoepitope | Biosource/Invitrogen, Camarillo CA, USA |
rpAb 42 | Aβx-42, neoepitope | Biosource/Invitrogen |
Special Aβ-antibodies | ||
mAb 27 | Aβ20-24 with Arc-mutation p.E22G | Lord et al. 2009 [19] |
mAb 2-48 | Aβ3pE | Synaptic Systems, Göttingen, Germany |
rpAb 11pE | Aβ11pE | Synaptic Systems |
Antibodies to cellular alterations | ||
mAb AT8 | Hyperphosphorylated tau | Innogenetics, Zwijndrecht, Belgium |
mAb GFAP | Glial fibrillary acidic protein | Dako, Glostrup, Denmark |
mAb HLA-DP, DQ, DR | Microglial cells | Dako |
rpAb Iba1 | Microglial cells | Wako, Osaka, Japan |
rpAbα1-antitrypsin | Lysosomes | Dako |
rpAb cathepsin D | Lysosomes | Dako (production discontinued) |